Addmedica Revenue and Competitors

Paris, France

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Addmedica's estimated annual revenue is currently $4.4M per year.(i)
  • Addmedica's estimated revenue per employee is $201,000

Employee Data

  • Addmedica has 22 Employees.(i)
  • Addmedica grew their employee count by -45% last year.

Addmedica's People

NameTitleEmail/Phone
1
Legal Department DirectorReveal Email/Phone
2
MSLReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$45.6M2270%N/AN/A
#2
$19.3M965%N/AN/A
#3
$36.2M1805%N/AN/A
#4
$34M16933%N/AN/A
#5
$173.7M86420%N/AN/A
#6
$45M2242%N/AN/A
#7
$48.2M2406%N/AN/A
#8
$22.1M1108%N/AN/A
#9
$22.1M110-13%N/AN/A
#10
$27.5M1371%N/AN/A
Add Company

What Is Addmedica?

addmedica is a fast growing company focused on developing and marketing medical products for: • rare diseases • unmet medical needs in developed and emerging countries • serious conditions addmedica is dedicated to providing high medical value to physicians, patients, and managed care organizations, by developing, registering and marketing a wide range of medical products in several rare and debilitating diseases. addmedica's strategic areas of interest comprise: • wound healing, tissue growth and cell regeneration • organ transplant, tissue replacement • genetic diseases, drug or substitute therapy, cell or gene therapy addmedica, complying with its pharmaceutical status, is proud to offer a range of products in the fields of • lung transplantation, • wound healing and deep burn care. • sickle cell disease (European Orphan Medicinal Product) addmedica is constantly looking for new opportunities and partnerships, to develop and commercialize products with high medical demand. As a result of its know-how, its commitment and its positioning, addmedica is ready to become a leading firm for the provision of medical products and innovative techniques for rare diseases with the best quality of services.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$4.4M

Revenue (est)

-45%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Addmedica News

2022-04-17 - Global Sickle Cell Disease Drug Market 2022 Industry Insights ...

Addmedica SAS; Angiocrine Bioscience Inc; Annexin Pharmaceuticals AB; ArQule Inc; Bio Products Laboratory Ltd; Bioverativ Inc; bluebird bio Inc; Bristol-Myers...

2022-04-13 - Sickle Cell Anemia Therapeutics Market Share And Size 2022 ...

Addmedica; Gamida Cell; Glycomimetics; Pfizer; Novartis; Global Blood Therapeutics; Micelle Biopharma; Bluebird Bio; Prolong Pharmaceuticals...

2022-04-13 - Sickle Cell Disease Drug Market Size, Share, Growth 2022 ...

Addmedica SAS; Angiocrine Bioscience Inc; Annexin Pharmaceuticals AB; ArQule Inc; Bio Products Laboratory Ltd; Bioverativ Inc; bluebird bio Inc...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.2M22N/AN/A
#2
$2.2M22N/AN/A
#3
$2.2M22N/AN/A
#4
$3.9M22N/AN/A
#5
$4.2M225%N/A